GPX8: A Potential Drug Target and Biomarker for Glutathione Peroxidase 8

Target Name: GPX8

NCBI ID: G493869

GPX8

GPX8: A Potential Drug Target and Biomarker for Glutathione Peroxidase 8

Glutathione peroxidase 8 (GPX8) is a protein that is expressed in a variety of tissues throughout the body. It is a key enzyme in the antioxidant response, which helps to protect cells from damage caused by free radicals. In recent years, researchers have become increasingly interested in GPX8 as a potential drug target and biomarker for a variety of diseases.

GPX8 is a member of the superfamily of cysteine 鈥嬧?媝rotease, which includes a group of enzymes that play a central role in the detoxification of harmful substances. These enzymes are involved in a variety of cellular processes, including the neutralization of toxic substances , the removal of foreign particles, and the regulation of cellular signaling pathways.

One of the unique features of GPX8 is its role in the detoxification of peroxides, which are unstable molecules that can damage cellular components and contribute to a variety of diseases, including cancer, neurodegenerative disorders, and cardiovascular diseases. peroxides are highly reactive and can react with a variety of molecules, including oxygen, to form peroxyl radicals (ROS). These ROS can damage cellular components and contribute to the development of diseases.

GPX8 is involved in the detoxification of peroxides by catalyzing the conversion of peroxides to less reactive compounds, such as water and carbon dioxide. This process involves a series of steps, including the formation of a peroxidase-complex, the transfer of a peroxidase substrate, and the conversion of the peroxidase substrate to a less reactive product.

Studies have shown that GPX8 is expressed in a variety of tissues and is involved in a variety of cellular processes, including the detoxification of peroxides, cell signaling, and inflammation. It is also expressed in a variety of diseases, including cancer, neurodegenerative disorders, and cardiovascular diseases.

In addition to its role in the detoxification of peroxides, GPX8 is also involved in the regulation of cellular signaling pathways. It has been shown to play a role in a variety of signaling pathways, including the TGF-β pathway, the NF-kappa-B pathway , and the PI3K/Akt pathway.

GPX8 has also been shown to play a role in the development and progression of a variety of diseases. For example, it has been shown to be involved in the development of cancer, neurodegenerative disorders, and cardiovascular diseases. involved in the progression of diseases such as rheumatoid arthritis, asthma, and diabetes.

In conclusion, GPX8 is a protein that is expressed in a variety of tissues throughout the body and is involved in a variety of cellular processes, including the detoxification of peroxides, cell signaling, and inflammation. It is also involved in the regulation of cellular signaling pathways and has been shown to play a role in the development and progression of a variety of diseases. As a result, GPX8 is a potential drug target and biomarker for a variety of diseases.

(GPX8 is a protein expressed in a variety of tissues and organs and participates in intracellular antioxidant responses, cell signaling and inflammatory processes. It is also involved in free radical scavenging and apoptosis processes. GPX8 is expressed in a variety of diseases, Including cancer, neurodegenerative diseases and cardiovascular diseases. In addition, it is closely related to cell signaling pathways, free radical scavenging and apoptosis processes. GPX8 is a potential drug target and biomarker.)

Protein Name: Glutathione Peroxidase 8 (putative)

The "GPX8 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GPX8 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets